To investigate the prognostic significance of immunological TME of brain metastasis, the OS rate of cohort 2 after brain surgery was studied in terms of the amount of CD3+ and PD1+ TILs, and PD-L1 expression on tumor cells. The gene discussed is CD274; the disease is neoplasm.